The EASEE brain stimulation system, first developed in Germany by PRECISIS, is designed to treat epilepsy without opening the ...

The treatment targets the SCN1A gene, which helps the brain produce a protein that controls electrical activity and prevents ...

Patients who experience acute symptomatic seizures have a low chance of developing unprovoked seizures later, even when ...

The tonic-clonic seizures treatment market was valued at USD 34.93 billion in 2023. The market is expected to grow at a CAGR of 6% during the period 2024-2032, reaching USD 55.84 billion by 2032. This ...

Investigational azetukalner met its primary endpoint of reducing focal onset seizure frequency across two doses, initial findings from the phase III X-TOLE2 trial showed. Over 12 weeks, adjunctive ...

Please provide your email address to receive an email when new articles are posted on . Monthly seizure frequency percentage reduction was 68.73% for the entire study cohort. For those followed up in ...

Egyptian fruit bats flew more slowly after eating alcohol-laced food. Now the urine strips that caught boozy wild chimps may be used on wild bats. Teen Heart Health Scores Average 68.3 in Ninth Grade ...

Longitudinal data suggested that treatment-resistant focal epilepsy may improve over time. Nearly 70% had reduced seizure frequency and some patients achieved seizure freedom. Improvement was not ...

Newswise — Status epilepticus (SE) is the most common neurologic emergency, with rates estimated between 1.3 and 81 cases per 100,000 people per year. Mortality estimates also range widely, between 3% ...

Please provide your email address to receive an email when new articles are posted on . In the TELSTAR open-label trial, Ruijter and colleagues analyzed data from 172 comatose survivors of cardiac ...

Two new models could solve a problem that's long frustrated millions of people with epilepsy and the doctors who treat them: how to find precisely where seizures originate to treat exactly that part ...

Keeping newborns on antiseizure medication after acute neonatal seizures stopped did not change development outcomes or prevent epilepsy, a comparative effectiveness study showed. No difference was ...